TD Cowen downgraded PhenomeX (CELL) to Market Perform from Outperform with a $1 price target, citing Bruker’s (BRKR) plans to acquire the company.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CELL:
